X

Mangalam Drugs & Organics Ltd. Stock Analysis

Small Cap
Evaluated by 708 users | BSE: 532637 | NSE: MANGALAM |
Pharmaceuticals & Drugs
Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.The...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 8%8.13%-4.87%3.78%12.9%19.82%21.97%17.06%-1.23%9.92%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 127153125123221295303279228282
Y-o-Y Gr. Rt.-20.4%-18.2%-2.2%80%33.8%2.7%-7.8%-18.5%24.1%
Adjusted EPS (Rs.) 1.520.39-8.98-2.324.711.2314.5212.28-5.115.19
Y-o-Y Gr. Rt.--74.3%-2402.6%NANA138.9%29.3%-15.4%-141.6%NA
Book Value per Share (Rs.) 28.428.8819.9317.6222.2836.8954.1565.5660.4465.67
Adjusted Net Profit 20.5-11.8-3.16.216.22319.4-8.18.2
Net Op. Cash Flow (Rs. Cr.) 7.17.1-0.77.51421.842.824.621.730.6
Debt to Cash Flow from Ops 7.238.64-110.3510.315.582.741.542.82.91.64
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Mangalam Drugs & Organics Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 9.3%5.1%-2.3%24.1%
Adjusted EPS 14.6%2%-29%NA
Book Value per Share 9.824.16.68.7
Share Price 31.1% -15.5% -2.4% 413.8%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 5.091.37-36.78-12.3523.5635.5431.2220.52-8.128.23
Operating Profit Margin (%) 9.869.26-3.527.859.2612.7815.516.774.288.41
Net Profit Margin (%) 1.570.34-9.44-2.492.815.477.596.96-3.562.91
Debt to Equity 1.371.62.773.322.651.130.770.660.660.48
Working Capital Days 148141175188152130114130162136
Cash Conversion Cycle 11797121123675658628347
Entity Percentage Holding
Promoters 50.53%
Institutions 0.01%
Non-Institutions 49.46%
Pledged *19.2523.5224.9426.570.000.000.0061.8961.8933.57
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Mangalam Drugs & Organics Ltd.'s performance infers:

Mangalam Drugs & Organics Ltd. earnings have grown by 2%, whereas share price has depreciated -15.5% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Mangalam Drugs & Organics Ltd. share prices over the last 10 years. Here is what we found out:

Mangalam Drugs & Organics Ltd. share price has depreciated 23.7% annually over the past ten years.

Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

The company manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a

Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

The company manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

The Company has a diversified product range having synergies in operations and substantial economies of scale. It is amongst the top three manufacturers in India in almost all the products that it manufactures.

Today Mangalam Drugs & Organics enjoys a very strong brand name in the domestic market. It has over two decades of experience in the industry with a very wide and satisfied customer base.

The company has a state of art multi-product manufacturing facilitiesat Vapi in Gujarat and Sangamner in Maharashtra for production of bulkdrugs perfumery chemicals inorganic chemicals and disperse dyesintermediaries with a strong in-house Research and Development base.

Product range of the company includes:

Active Pharma Ingredients (API)

  • Anti Malarial
  • Analgesic / Anti Inflammatory
  • Diuretic
  • Anti Hypertensive
  • Anti Convulsant

API Under Development

  • Intermediates
  • Antiurolithic

Prefumery / Specialty Chemicals

  • Phenyl Ethyl Alcohol
  • Phenyl Ethyl Methyl Ether
  • Phenyl Ethyl Acetate

Disperse Dye Intermediates

  • Meta Nitro Aniline (Mna)(99-09-2)
  • Meta Amino Propionilide (MAP)
  • Meta Amino Acetanilide (MAA) (162-28-3)
  • Para Amino Acetanilide (PAA) 122-80-5)
  • Para Amino Propionilide (PAP) (59690-89-0)
  • N-Cyano Ethyl Aniline (1075-76-9)
  • N,N-BIS (2-Hydroxy Ethyl) Meta Chloro Aniline (Mangalam-1) (92-00-2)
  • N,N-BIS (2-Acetoxy Ethyl) Meta Chloro Aniline (Mangalam -1A) (26692-46-6) etc.

Achievements/ recognition:

  • Awarded the ISO 9001:2000 Management System Certificate from DNV for Design Development, Manufacture and supply of Bulk Drugs, and Dyes Intermediates.
  • Received the WHO GMP Certificate for its Bulk Drug manufacturing Plant
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback